The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
ABSTRACTAcute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now be...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Taylor & Francis Group
2024-12-01
|
| Sarja: | Human Vaccines & Immunotherapeutics |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2311969 |